Company

Porton Advanced Solution

Porton Advanced provides development, testing, and manufacturing services for cell and gene therapies.

About

Founded in 2018 and based in Jiangsu, China, Porton Advanced is a subsidiary of Porton Pharma Solutions. It provides process and analytical development, testing, GMP manufacturing, and discovery research for therapeutic products at pre-clinical, clinical, and commercial stages. In August 2022, it raised USD 80 million in Series B funding led by China Merchants Group Limited, with participation from China Merchants Capital, China Merchants Securities, Chongqing Porton Fine Chemicals Co., Ltd., CS Capital, Fosun Health Capital, Gortune Investment, HM Capital, Momentum Venture Capital, Ruilian Investment, and SDICTK.

1Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in